SPARC and neoplasm: As a nanoparticle albumin-bound formulation, nab-paclitaxel targets secreted protein acidic and rich in cysteine (SPARC) within the tumor stroma, reducing desmoplasia and enhancing vascular permeability—thereby improving gemcitabine delivery (16).